IP Library Assignment 031086/0388
Patent Assignment
Reel/Frame 031086/0388

Change of Name

Recorded: 2013-08-26 Pages: 8
Assignor
AMYLIN PHARMACEUTICALS, INC.
Executed: 2012-08-08
Assignee
AMYLIN PHARMACEUTICALS, LLC
9360 TOWNE CENTRE DRIVE, ATTN: INTELLECTUAL PROPERTY GROUP, SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
Treatment of Hibernating Myocardium with an Exendin Peptide
Patent: 8,551,947 →
Application: 12/945,702 →
Publication: US 2012/0302501
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Nov 8, 2011
From: AMYLIN PHARMACEUTICALS, INC.
To: ELI LILLY AND COMPANY
Reel/Frame 027192/0334 →
Release of Security Interest Oct 1, 2012
From: ELI LILLY AND COMPANY
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 029057/0342 →
Amylin Pharmaceuticals, Llc Assigns an Equal and Undivided One-Half of Its Entire Right, Title and Interest to Astrazeneca Aug 26, 2013
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 031086/0431 →